Cholesteryl ester transfer protein and coronary artery disease - An observation with therapeutic implications

被引：12
作者：
Wolfe, ML
Rader, DJ
机构：
[1] Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
来源：
CIRCULATION | 2004年 / 110卷 / 11期
关键词：
editorials; cholesterol; lipoproteins; atherosclerosis; coronary disease;
D O I：
10.1161/01.CIR.0000143047.52724.BB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1338 / 1340
页数：3
相关论文
共 20 条
  • [1] Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197
  • [2] Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis
    Barter, PJ
    Brewer, HB
    Chapman, MJ
    Hennekens, CH
    Rader, DJ
    Tall, AR
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) : 160 - 167
  • [3] Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease
    Blankenberg, S
    Rupprecht, HJ
    Bickel, C
    Jiang, XC
    Poirier, O
    Lackner, KJ
    Meyer, J
    Cambien, F
    Tiret, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 1983 - 1989
  • [4] Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study
    Boekholdt, SM
    Kuivenhoven, JA
    Wareham, NJ
    Peters, RJG
    Jukema, JW
    Luben, R
    Bingham, SA
    Day, NE
    Kastelein, JJP
    Khaw, KT
    [J]. CIRCULATION, 2004, 110 (11) : 1418 - 1423
  • [5] Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
    Boekholdt, SM
    Thompson, JF
    [J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (06) : 1080 - 1093
  • [6] Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol
    Brousseau, ME
    Schaefer, EJ
    Wolfe, ML
    Bloedon, LT
    Digenio, AG
    Clark, RW
    Mancuso, JP
    Rader, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1505 - 1515
  • [7] Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib
    Clark, RW
    Sutfin, TA
    Ruggeri, RB
    Willauer, AT
    Sugarman, ED
    Magnus-Aryitey, G
    Cosgrove, PG
    Sand, TM
    Wester, RT
    Williams, JA
    Perlman, ME
    Bamberger, MJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) : 490 - 497
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
    Curb, JD
    Abbott, RD
    Rodriguez, BL
    Masaki, K
    Chen, R
    Sharp, DS
    Tall, AR
    [J]. JOURNAL OF LIPID RESEARCH, 2004, 45 (05) : 948 - 953
  • [10] The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia
    de Grooth, GJ
    Smilde, TJ
    van Wissen, S
    Klerkx, AHEM
    Zwinderman, AH
    Fruchart, JC
    Kastelein, JJP
    Stalenhoef, AFH
    Kuivenhoven, JA
    [J]. ATHEROSCLEROSIS, 2004, 173 (02) : 261 - 267
12